MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$7,103K
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
Research and development
2,704
1,854
Selling, general and administrative
3,720
3,780
Total operating expenses
6,424
5,634
Loss from operations
-6,424
-5,634
Change in fair value of derivative liability
47
33
Interest income
11
24
Interest expense
691
648
Net other (expense) income
-633
-591
Net loss from operations before discontinued operations
-7,057
-6,225
Revenue
-
24
Cost of sales
-
3
Gross profit
-
21
Selling, general and administrative
-
-2
Total operating expenses
-
-2
Loss from discontinued operations
-46
23
Net loss
-7,103
-6,202
Basic EPS
-2.17
-2.23
Basic Average Shares
3,379,997
2,883,650
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
-$7,103K
Net loss from
operations before...
-$7,057K
Loss from
discontinued operations
-$46K
Loss from operations
-$6,424K
Net other (expense)
income
-$633K
Change in fair value of
derivative liability
$47K
Interest income
$11K
Total operating
expenses
$6,424K
Interest expense
$691K
Selling, general and
administrative
$3,720K
Research and development
$2,704K
Buy us a coffee
Valion Bio, Inc. (VBIO)
Valion Bio, Inc. (VBIO)